151 related articles for article (PubMed ID: 22231432)
1. Prognostic value of plasmatic tumor M2 pyruvate kinase and carcinoembryonic antigen in the survival of colorectal cancer patients.
Fatela-Cantillo D; Fernandez-Suarez A; Moreno MA; Gutierrez JJ; Iglesias JM
Tumour Biol; 2012 Jun; 33(3):825-32. PubMed ID: 22231432
[TBL] [Abstract][Full Text] [Related]
2. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
[TBL] [Abstract][Full Text] [Related]
3. A comparison of tumour M2-PK with carcinoembryonic antigen and CA19-9 in patients undergoing liver resection for colorectal metastases.
Kumar Y; Pinedo IR; Tapuria N; Zabron A; Davidson BR
Eur J Gastroenterol Hepatol; 2008 Oct; 20(10):1006-11. PubMed ID: 18787469
[TBL] [Abstract][Full Text] [Related]
4. Tumor-specific correlation of tumor M2 pyruvate kinase in pre-invasive, invasive and recurrent cervical cancer.
Landt S; Jeschke S; Koeninger A; Thomas A; Heusner T; Korlach S; Ulm K; Schmidt P; Blohmer JU; Lichtenegger W; Sehouli J; Kuemmel S
Anticancer Res; 2010 Feb; 30(2):375-81. PubMed ID: 20332442
[TBL] [Abstract][Full Text] [Related]
5. Comparison of tumor M2-pyruvate kinase (tumor M2-PK), carcinoembryonic antigen (CEA), carbohydrate antigens CA 19-9 and CA 72-4 in the diagnosis of gastrointestinal cancer.
Schneider J; Schulze G
Anticancer Res; 2003; 23(6D):5089-93. PubMed ID: 14981971
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic and prognostic value of plasma tumor M2 pyruvate kinase in periampullary cancer: evidence for a novel biological marker of adverse prognosis.
Goonetilleke KS; Mason JM; Siriwardana P; King NK; France MW; Siriwardena AK
Pancreas; 2007 Apr; 34(3):318-24. PubMed ID: 17414054
[TBL] [Abstract][Full Text] [Related]
7. Tumor type M2 pyruvate kinase expression in gastric cancer, colorectal cancer and controls.
Zhang B; Chen JY; Chen DD; Wang GB; Shen P
World J Gastroenterol; 2004 Jun; 10(11):1643-6. PubMed ID: 15162541
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the tumor markers tumor M2-PK, CEA, CYFRA 21-1, NSE and SCC in the diagnosis of lung cancer.
Schneider J; Velcovsky HG; Morr H; Katz N; Neu K; Eigenbrodt E
Anticancer Res; 2000; 20(6D):5053-8. PubMed ID: 11326667
[TBL] [Abstract][Full Text] [Related]
9. Tumor M2-pyruvate kinase, a new metabolic marker for pancreatic cancer.
Ventrucci M; Cipolla A; Racchini C; Casadei R; Simoni P; Gullo L
Dig Dis Sci; 2004 Aug; 49(7-8):1149-55. PubMed ID: 15387337
[TBL] [Abstract][Full Text] [Related]
10. YAP Levels Combined with Plasma CEA Levels Are Prognostic Biomarkers for Early-Clinical-Stage Patients of Colorectal Cancer.
Xu Z; Wang H; Gao L; Zhang H; Wang X
Biomed Res Int; 2019; 2019():2170830. PubMed ID: 31886181
[TBL] [Abstract][Full Text] [Related]
11. Tumour M2-PK as a predictor of surgical outcome in ovarian cancer, a prospective cohort study.
Ahmed AS; Dew T; Lawton FG; Papadopoulos AJ; Devaja O; Raju KS; Sherwood RA
Eur J Gynaecol Oncol; 2007; 28(2):103-8. PubMed ID: 17479670
[TBL] [Abstract][Full Text] [Related]
12. Prognostic role of carcinoembryonic antigen is influenced by microsatellite instability genotype and stage in locally advanced colorectal cancers.
Søreide K; Søreide JA; Kørner H
World J Surg; 2011 Apr; 35(4):888-94. PubMed ID: 21301835
[TBL] [Abstract][Full Text] [Related]
13. Tumour M2-pyruvate kinase: a gastrointestinal cancer marker.
Kumar Y; Tapuria N; Kirmani N; Davidson BR
Eur J Gastroenterol Hepatol; 2007 Mar; 19(3):265-76. PubMed ID: 17301655
[TBL] [Abstract][Full Text] [Related]
14. Correlation of the Serum Level of Carcinoembryonic Antigen and Prolactin with Different Stages of Colorectal Carcinoma According to Dukes' Staging.
Rahman MR; Sheikh SH; Lima IJ; Islam MR; Faisal M; Islam MS; Faruk MO; Jalal MT
Mymensingh Med J; 2016 Jan; 25(1):61-5. PubMed ID: 26931251
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of preoperative carcinoembryonic antigen and D-dimer concentrations in patients undergoing curative resection for colorectal cancer.
Ojima Y; Harano M; Sumitani D; Yoshimitsu M; Okajima M
Surg Today; 2021 Jul; 51(7):1108-1117. PubMed ID: 33386463
[TBL] [Abstract][Full Text] [Related]
16. Preoperative serum carcinoembryonic antigen, albumin and age are supplementary to UICC staging systems in predicting survival for colorectal cancer patients undergoing surgical treatment.
Sun LC; Chu KS; Cheng SC; Lu CY; Kuo CH; Hsieh JS; Shih YL; Chang SJ; Wang JY
BMC Cancer; 2009 Aug; 9():288. PubMed ID: 19691850
[TBL] [Abstract][Full Text] [Related]
17. [Predictive value of combination detection of tissue Pgp1 expression and preoperative serum CEA level for colorectal cancer].
Wu F; Chen L; Wu W; Jiang B; Su X
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):443-449. PubMed ID: 28440527
[TBL] [Abstract][Full Text] [Related]
18. Plasma Tumor M2-Pyruvate Kinase Levels in Different Cancer Types.
Muñoz-Colmenero A; Fernández-Suárez A; Fatela-Cantillo D; Ocaña-Pérez E; Domínguez-Jiménez JL; Díaz-Iglesias JM
Anticancer Res; 2015 Jul; 35(7):4271-6. PubMed ID: 26124389
[TBL] [Abstract][Full Text] [Related]
19. Tumor M2 pyruvate kinase in plasma of patients with urological tumors.
Roigas J; Schulze G; Raytarowski S; Jung K; Schnorr D; Loening SA
Tumour Biol; 2001; 22(5):282-5. PubMed ID: 11553857
[TBL] [Abstract][Full Text] [Related]
20. Tumor type M2 pyruvate kinase expression in advanced breast cancer.
Lüftner D; Mesterharm J; Akrivakis C; Geppert R; Petrides PE; Wernecke KD; Possinger K
Anticancer Res; 2000; 20(6D):5077-82. PubMed ID: 11326672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]